SiteRx at a Glance

SiteRx makes it easy and rewarding to refer your patients to clinical trials. See how it works.

FAQ

We are always happy to answer your specific questions but we have compiled some that we hear most commonly.

SiteRx Demo

See how SiteRx works by watching this short video.

Doctor Testimonials

Hear what doctors say about SiteRx!

PI vs. SiteRx

See how one doctor stayed focused on her clinical practice but still got her patients the new treatment options they needed.

FAQ: Business Associates

When SiteRx partners with a provider, we sign a Business Associate Agreement and become an extension of the provider to perform defined services on behalf of the practice.

Data Security

SiteRx extracts the data from provider's EHR system through an end-to-end secure channel. 

HIPAA Certification

Read our certification from Accountable.

New Study

See which study is now enrolling new patients.

Now Recruiting: Seikagaku

Seikagaku is recruiting for lumbar disc herniation patients. SI-6603 is among the largest actively recruiting lumbar disc herniation studies globally.

Now Recruiting: Novartis

ARTIOS is actively recruiting for a Phase III study, targeting patients with Relapsing Multiple Sclerosis.

Now Recruiting: Prevail

Prevail is recruiting a small number of patients with Frontotemporal Dementia (FTD.) 

Now Recruiting: Roche

Gantenerumab, a large Phase II trial led by Hoffmann-LaRoche is now recruiting mild Cognitive Impairment or Mild Alzheimer's Disease with MMSE > 22.

Now Recruiting: Eisai

E2027 is a phase 2, open-label 9-month trial.  E2027 is actively recruiting nationally for DLB and PDD populations

Back To Top